comparemela.com

Company Galahead News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sirnaomics will Present its Innovative Dual-Targeted GalNAc muRNA Programs in 2024 OPT Conference

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, March 12, 2024 /PRNewswire/ Sirnaomics Ltd. , a leading biopharmaceutical company engaging in discovery and development of advanced RNAi.

United statesJim weteringsCompany galaheadPrnewswire sirnaomics ltdRna therapeutics congressRna therapeutics congress presentation detailsGroup or sirnaomicsCongress presentationTherapeutic platformVice presidentPlenary keynote sessionPlenary chairperson

Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707 for Solid Tumors

Sirnaomics Ltd. (the "Company", Stock Code: 2257, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging .

Hong kongUnited statesPatrick luDavid evansSirnaomics ltdGroup or sirnaomicsCompany galaheadStock codeImmune checkpoint inhibitorExecutive directorChief executive officer

Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707 for Solid Tumors

Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707 for Solid Tumors
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesDavid evansPatrick luGroup or sirnaomicsPrnewswire sirnaomics ltdCompany galaheadStock codeImmune checkpoint inhibitorExecutive directorChief executive officer

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress

Sirnaomics CTO Dmitry Samarsky, PhD, to Also Present OPT Congress Opening Remarks GAITHERSBURG, Md. and SUZHOU, China, March 14, 2022 /PRNewwire/ Sirnaomics.

United statesNigel yipBunny leeDmitry samarskyAlexis feinbergPatrick luCompany galaheadSirnaomics ltdCongress openingRevere hotel boston commonCambridge healthtech instituteAlso presentPrecision therapeuticsSirnaomics chief technology officerTriggers composedSirnaomics chief technology

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress

Sirnaomics CTO Dmitry Samarsky, PhD, to Also Present OPT Congress Opening Remarks GAITHERSBURG, Md. and SUZHOU, China, March 15, 2022 /PRNewwire/ Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced today that it will present the latest developments on its GalNAc-Liver-Targeting platforms and product pipeline at the Oligonucleotide &.

United statesNigel yipBunny leeDmitry samarskyAlexis feinbergPatrick luCompany galaheadSirnaomics ltdCongress openingRevere hotel boston commonCambridge healthtech instituteAlso presentPrecision therapeuticsSirnaomics chief technology officerTriggers composedSirnaomics chief technology

vimarsana © 2020. All Rights Reserved.